Abiozen’s CRO360™ division stands at the forefront of therapeutic innovation, offering deep domain expertise across a spectrum of high-impact disease areas. Our ability to successfully execute complex clinical trials stems from a foundation of scientific excellence, patient-focused design, and operational precision. With a portfolio of over 20 oncology studies and numerous trials in rare and chronic diseases, we accelerate therapeutic breakthroughs for sponsors across the globe. Each program is informed by real-world evidence, biomarker-driven strategies, and digital integration—ensuring faster recruitment, superior data quality, and regulatory alignment.

Oncology
Our oncology practice spans solid tumors, hematologic malignancies, and advanced immunotherapies such as CAR-T and checkpoint inhibitors. We are adept at navigating complex protocols, stringent safety oversight, and global recruitment strategies. With a specialized oncology site network and proven experience in over 20 studies, we deliver speed, safety, and precision in one of the most demanding therapeutic areas. Inspired by Curia Global’s leadership in immuno-oncology, our approach is at the cutting edge of cancer research.

Neurology
We support trials across a wide range of central nervous system (CNS) disorders, including Alzheimer’s, Parkinson’s, Multiple Sclerosis, and rare neurological conditions. Our decentralized trial model leverages mobile health platforms, cognitive testing tools, and advanced neuroimaging to ensure robust, patient-centric data collection. We have pioneered gene therapy trials in this space, setting benchmarks for innovation and care. Our neurology model is closely aligned with Thermo Fisher Patheon’s decentralized CNS capabilities.

Endocrinology
Our team brings experience in managing trials for diabetes, thyroid dysfunction, and metabolic syndromes. We integrate wearable technology, real-time glucose monitoring, and patient-reported outcome tools to improve data granularity and participant compliance. Our endocrinology trials are designed for scalability, targeting both adult and pediatric populations in diverse care settings.

Ophthalmology
In the field of ophthalmology, we deliver studies for retinal disorders, macular degeneration, and glaucoma with precision imaging and validated visual function endpoints. Our teams collaborate with retina specialists and leverage high-resolution diagnostics to ensure statistically robust and clinically meaningful outcomes.

Cardiology
Our cardiovascular trial capabilities include studies for heart failure, arrhythmias, ischemic heart disease, and interventional cardiology devices. We ensure rigorous ECG monitoring, real-time telemetry, and endpoint adjudication to support regulatory submissions with high-quality cardiac safety and efficacy data.

Infectious Diseases
Abiozen is actively involved in clinical development of antivirals, vaccines, and antimicrobial therapies across multiple geographies. With access to high-risk populations and outbreak regions through our global site network, we enable rapid recruitment and delivery of diverse clinical datasets. Informed by Thermo Fisher CRDMO’s infectious disease leadership, our model supports fast-track execution and accelerated market readiness.